Literature DB >> 19200960

Vitrification is a highly efficient method to cryopreserve human embryos in in vitro fertilization patients at high risk of developing ovarian hyperstimulation syndrome.

Helmy Selman1, Gian Francesco Brusco, Fabrizio Fiorini, Nicoletta Barnocchi, Monica Mariani, Imam El-Danasouri.   

Abstract

This study aimed to evaluate the efficacy of embryo vitrification as an emergency procedure for patients at high risk of developing ovarian hyperstimulation syndrome (OHSS). A total of 69 embryos, derived from 24 patients for whom embryo transfer could not be performed because of the risk of developing OHSS, were vitrified and warmed for deferred embryo transfer. Surviving embryos were transferred, resulting in 10 clinical pregnancies, of which 4 were successfully delivered and the remaining 6 are still ongoing.

Entities:  

Mesh:

Year:  2009        PMID: 19200960     DOI: 10.1016/j.fertnstert.2008.12.027

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  5 in total

1.  Human cleavage-stage embryo vitrification is comparable to slow-rate cryopreservation in cycles of assisted reproduction.

Authors:  Martin Graham Wilding; Clemente Capobianco; Nadia Montanaro; Genc Kabili; Loredana Di Matteo; Enrico Fusco; Brian Dale
Journal:  J Assist Reprod Genet       Date:  2010-07-17       Impact factor: 3.412

Review 2.  Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment.

Authors:  Klaus Fiedler; Diego Ezcurra
Journal:  Reprod Biol Endocrinol       Date:  2012-04-24       Impact factor: 5.211

3.  A Personalized Management Approach of OHSS: Development of a Multiphase Prediction Model and Smartphone-Based App.

Authors:  Mingzhu Cao; Zhi Liu; Yanshan Lin; Yiqun Luo; Sichen Li; Qing Huang; Haiying Liu; Jianqiao Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-06       Impact factor: 6.055

4.  Testing the efficacy and efficiency of a single "universal warming protocol" for vitrified human embryos: prospective randomized controlled trial and retrospective longitudinal cohort study.

Authors:  L Parmegiani; K H Beilby; A Arnone; S Bernardi; A M Maccarini; E Nardi; G E Cognigni; M Filicori
Journal:  J Assist Reprod Genet       Date:  2018-08-03       Impact factor: 3.412

5.  Whether Letrozole could reduce the incidence of early ovary hyperstimulation syndrome after assisted reproductive technology? A systematic review and meta-analysis.

Authors:  Jing Zhao; Bin Xu; Xi Huang; Yi Yan; Yanping Li
Journal:  Reprod Health       Date:  2020-11-20       Impact factor: 3.223

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.